Clinical trial
Docetaxel With or Without Thalidomide in Treating Patients With Metastatic…
NCT00020046 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00020046 |
|---|---|
| Title | Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer |
| Official title | Phase II Randomized Study of Docetaxel With or Without Thalidomide in Patients With Androgen-Independent Metastatic Prostate Cancer |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stage IV Prostate Cancer, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, thalidomide |
| Start date | Dec 1, 1999 |
| Completion | Sep 1, 2003 |
| First posted | Mar 5, 2007 |
| Last update posted | Oct 31, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: